OSLO/LONDON, 9 June 2022: Reference is made to the stock exchange release by EXACT Therapeutics AS (“EXACT-Tx”, “the Company” Euronext Growth: EXTX) on 9 June 2022 regarding a share capital increase in connection with the Company's restricted stock unit (RSU) programme. 

Anders Wold, Chair of EXACT-Tx, has subscribed for 2,414 shares at NOK 19.00 per share. Following this transaction, Anders Wold will hold 2,414 shares in EXACT-Tx. Attached is the notification of trade of primary insider.